Pathstone Holdings’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Buy |
26,243
+1,089
| +4% | +$10.2K | ﹤0.01% | 1990 |
|
|
2025
Q1 | $179K | Buy |
25,154
+14,515
| +136% | +$103K | ﹤0.01% | 2088 |
|
|
2024
Q4 | $124K | Sell |
10,639
-2,905
| -21% | -$33.9K | ﹤0.01% | 2220 |
|
|
2024
Q3 | $278K | Sell |
13,544
-6
| -0% | -$123 | ﹤0.01% | 2007 |
|
|
2024
Q2 | $303K | Buy |
13,550
+747
| +6% | +$16.7K | ﹤0.01% | 1928 |
|
|
2024
Q1 | $352K | Buy |
12,803
+5,434
| +74% | +$149K | ﹤0.01% | 1838 |
|
|
2023
Q4 | $225K | Buy |
+7,369
| New | +$225K | ﹤0.01% | 2004 |
|